Anaplastic Large Cell T Cell Lymphoma in a Patient With Severe Therapy-refractory Crohn’s Disease on Long-standing Immunosuppressive Medication During Ustekinumab Treatment: A Case Report and Review of the Literature

Use of ustekinumab in Crohn’s disease was approved in 2016, and consequently data regarding its real-world safety are still limited. We here present a 29-year-old woman with severe therapy-refractory Crohn’s disease, who developed an anaplastic large cell T cell lymphoma during treatment with usteki...

Descripción completa

Detalles Bibliográficos
Autores principales: Smeets, Fabiënne G M, Liedorp, Paulien R, van der Poel, Marjolein, Miclea, Razvan L, Masclee, Ad A M, Pierik, Marieke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7142401/
https://www.ncbi.nlm.nih.gov/pubmed/31116402
http://dx.doi.org/10.1093/ecco-jcc/jjz084
_version_ 1783519372791250944
author Smeets, Fabiënne G M
Liedorp, Paulien R
van der Poel, Marjolein
Miclea, Razvan L
Masclee, Ad A M
Pierik, Marieke
author_facet Smeets, Fabiënne G M
Liedorp, Paulien R
van der Poel, Marjolein
Miclea, Razvan L
Masclee, Ad A M
Pierik, Marieke
author_sort Smeets, Fabiënne G M
collection PubMed
description Use of ustekinumab in Crohn’s disease was approved in 2016, and consequently data regarding its real-world safety are still limited. We here present a 29-year-old woman with severe therapy-refractory Crohn’s disease, who developed an anaplastic large cell T cell lymphoma during treatment with ustekinumab.
format Online
Article
Text
id pubmed-7142401
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-71424012020-04-13 Anaplastic Large Cell T Cell Lymphoma in a Patient With Severe Therapy-refractory Crohn’s Disease on Long-standing Immunosuppressive Medication During Ustekinumab Treatment: A Case Report and Review of the Literature Smeets, Fabiënne G M Liedorp, Paulien R van der Poel, Marjolein Miclea, Razvan L Masclee, Ad A M Pierik, Marieke J Crohns Colitis Short Reports Use of ustekinumab in Crohn’s disease was approved in 2016, and consequently data regarding its real-world safety are still limited. We here present a 29-year-old woman with severe therapy-refractory Crohn’s disease, who developed an anaplastic large cell T cell lymphoma during treatment with ustekinumab. Oxford University Press 2019-10 2019-05-22 /pmc/articles/PMC7142401/ /pubmed/31116402 http://dx.doi.org/10.1093/ecco-jcc/jjz084 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Short Reports
Smeets, Fabiënne G M
Liedorp, Paulien R
van der Poel, Marjolein
Miclea, Razvan L
Masclee, Ad A M
Pierik, Marieke
Anaplastic Large Cell T Cell Lymphoma in a Patient With Severe Therapy-refractory Crohn’s Disease on Long-standing Immunosuppressive Medication During Ustekinumab Treatment: A Case Report and Review of the Literature
title Anaplastic Large Cell T Cell Lymphoma in a Patient With Severe Therapy-refractory Crohn’s Disease on Long-standing Immunosuppressive Medication During Ustekinumab Treatment: A Case Report and Review of the Literature
title_full Anaplastic Large Cell T Cell Lymphoma in a Patient With Severe Therapy-refractory Crohn’s Disease on Long-standing Immunosuppressive Medication During Ustekinumab Treatment: A Case Report and Review of the Literature
title_fullStr Anaplastic Large Cell T Cell Lymphoma in a Patient With Severe Therapy-refractory Crohn’s Disease on Long-standing Immunosuppressive Medication During Ustekinumab Treatment: A Case Report and Review of the Literature
title_full_unstemmed Anaplastic Large Cell T Cell Lymphoma in a Patient With Severe Therapy-refractory Crohn’s Disease on Long-standing Immunosuppressive Medication During Ustekinumab Treatment: A Case Report and Review of the Literature
title_short Anaplastic Large Cell T Cell Lymphoma in a Patient With Severe Therapy-refractory Crohn’s Disease on Long-standing Immunosuppressive Medication During Ustekinumab Treatment: A Case Report and Review of the Literature
title_sort anaplastic large cell t cell lymphoma in a patient with severe therapy-refractory crohn’s disease on long-standing immunosuppressive medication during ustekinumab treatment: a case report and review of the literature
topic Short Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7142401/
https://www.ncbi.nlm.nih.gov/pubmed/31116402
http://dx.doi.org/10.1093/ecco-jcc/jjz084
work_keys_str_mv AT smeetsfabiennegm anaplasticlargecelltcelllymphomainapatientwithseveretherapyrefractorycrohnsdiseaseonlongstandingimmunosuppressivemedicationduringustekinumabtreatmentacasereportandreviewoftheliterature
AT liedorppaulienr anaplasticlargecelltcelllymphomainapatientwithseveretherapyrefractorycrohnsdiseaseonlongstandingimmunosuppressivemedicationduringustekinumabtreatmentacasereportandreviewoftheliterature
AT vanderpoelmarjolein anaplasticlargecelltcelllymphomainapatientwithseveretherapyrefractorycrohnsdiseaseonlongstandingimmunosuppressivemedicationduringustekinumabtreatmentacasereportandreviewoftheliterature
AT miclearazvanl anaplasticlargecelltcelllymphomainapatientwithseveretherapyrefractorycrohnsdiseaseonlongstandingimmunosuppressivemedicationduringustekinumabtreatmentacasereportandreviewoftheliterature
AT mascleeadam anaplasticlargecelltcelllymphomainapatientwithseveretherapyrefractorycrohnsdiseaseonlongstandingimmunosuppressivemedicationduringustekinumabtreatmentacasereportandreviewoftheliterature
AT pierikmarieke anaplasticlargecelltcelllymphomainapatientwithseveretherapyrefractorycrohnsdiseaseonlongstandingimmunosuppressivemedicationduringustekinumabtreatmentacasereportandreviewoftheliterature

Ejemplares similares